BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
+24.74%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$323M
AUM Growth
+$323M
(+21%)
Cap. Flow
+$99.9K
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
68.96%
Holding
57
New
9
Increased
14
Reduced
26
Closed
2
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$572K |
| 2 |
Palo Alto Networks
PANW
|
$394K |
| 3 |
UroGen Pharma
URGN
|
$321K |
| 4 |
Idexx Laboratories
IDXX
|
$233K |
| 5 |
Oracle
ORCL
|
$222K |
Top Sells
| 1 |
Apple
AAPL
|
$615K |
| 2 |
Meta Platforms (Facebook)
META
|
$454K |
| 3 |
lululemon athletica
LULU
|
$236K |
| 4 |
American Electric Power
AEP
|
$204K |
| 5 |
VMW
VMware, Inc
VMW
|
$197K |
Sector Composition
| 1 | Technology | 39.18% |
| 2 | Consumer Discretionary | 28.73% |
| 3 | Healthcare | 20.39% |
| 4 | Communication Services | 9.08% |
| 5 | Utilities | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$139B
| $2.82M | 0.87% |
34,044
-375
| -1% | -$31.1K |
|
27
Bristol-Myers Squibb
BMY
$96.4B
| $1.93M | 0.6% |
27,887
-60
| -0.2% | -$4.16K |
|
|
VMW
28
DELISTED
VMware, Inc
VMW
| $1.87M | 0.58% |
14,981
-1,574
| -10% | -$197K |
|
|
29
Palo Alto Networks
PANW
$128B
| $1.11M | 0.34% |
5,537
+1,972
| +55% | +$394K |
|
30
Costco
COST
$416B
| $913K | 0.28% |
1,837
-43
| -2% | -$21.4K |
|
31
Merck
MRK
$212B
| $899K | 0.28% |
8,452
-140
| -2% | -$14.9K |
|
32
Abbott
ABT
$228B
| $883K | 0.27% |
8,721
-5
| -0.1% | -$506 |
|
33
Cognizant
CTSH
$35.1B
| $877K | 0.27% |
14,399
-645
| -4% | -$39.3K |
|
34
Johnson & Johnson
JNJ
$428B
| $857K | 0.27% |
5,531
+34
| +0.6% | +$5.27K |
|
35
Pfizer
PFE
$141B
| $825K | 0.26% |
20,220
-410
| -2% | -$16.7K |
|
36
Paychex
PAYX
$48.8B
| $783K | 0.24% |
6,835
| – | – |
|
37
Deere & Co
DE
$128B
| $645K | 0.2% |
1,561
| – | – |
|
38
Nucor
NUE
$33.6B
| $626K | 0.19% |
4,055
-80
| -2% | -$12.4K |
|
39
Boeing
BA
$180B
| $625K | 0.19% |
2,940
| – | – |
|
40
Norfolk Southern
NSC
$62.1B
| $599K | 0.19% |
2,826
-625
| -18% | -$133K |
|
|
41
BioCryst Pharmaceuticals
BCRX
$1.75B
| $572K | 0.18% |
+68,600
| New | +$572K |
|
42
JPMorgan Chase
JPM
$821B
| $531K | 0.16% |
4,078
-56
| -1% | -$7.3K |
|
43
Caterpillar
CAT
$194B
| $370K | 0.11% |
1,617
| – | – |
|
44
Target
TGT
$42B
| $340K | 0.11% |
2,055
-25
| -1% | -$4.14K |
|
|
45
UroGen Pharma
URGN
$889M
| $321K | 0.1% |
+34,701
| New | +$321K |
|
46
Visa
V
$677B
| $253K | 0.08% |
1,120
| – | – |
|
47
Duke Energy
DUK
$94.8B
| $246K | 0.08% |
2,549
-77
| -3% | -$7.43K |
|
48
T Rowe Price
TROW
$23B
| $241K | 0.07% |
2,135
| – | – |
|
|
49
Idexx Laboratories
IDXX
$51.1B
| $233K | 0.07% |
+465
| New | +$233K |
|
|
50
Oracle
ORCL
$629B
| $222K | 0.07% |
+2,389
| New | +$222K |
|